After 12 years’ waiting, the 4th version of the Patent Law with an aim of further motivating innovations and improving the mechanism for cracking down patent infringements was finally passed on October 17, 2020. The amended Chinese patent law will take effect on June 1, 2021. Second Amendments introduced pharmaceutical patent-term extensions and established an early pharmaceutical patent-dispute resolution mechanism and patent linkage system that further protects the rights of patentees.

The European Chamber is delighted to invite Ms Mi LI, Principal at Rouse and the IP Consulting Director of Rouse China in Beijing to break down the changes and challenges, as well as outlooks ahead for our members in the pharmaceutical sector.

• 2020-11-20 | 14:00 - 15:40
• Zoom Online Meeting & Rouse Office

The global pandemic has further accelerated the digital transformation of businesses resulting in increased reliance on e-commerce platforms, boom in the AI-related industries and digitalisation of production and delivery processes. With digitalisation of businesses, consumption too has increasingly moved online. Intellectual property (IP) is crucial to digital economy as it drives innovation and provides SMEs with comparative advantage over competitors. While digital economy brings about new IP risks like online infringements, it also creates new solutions for IP protection such as the use of blockchain technologies or reliance on sophisticated notice and take-down systems on e-commerce platforms or even the use of internet courts speeding up IP enforcement procedures. To be successful in digital economy, SMEs should focus on protecting their IP by adopting a comprehensive IP strategy taking into account the needs of digital economy.

• 2020-11-18 | 15:00 - 17:00
• Zoom Online Meeting

The European Chamber is delighted to invite you to our joint working group meeting on the latest updates on business compliance in data and personal information regulations by having an outlook on Personal Information Protection Law (Draft) in China and EU's Schrems II Judgement with Ms. Ying Jiang from LEGO and Dr. Ralf Sauer from DG JUST, the European Commission.

• 2020-11-05 - 2020-11-05 | 15:15 - 16:50
• European Chamber Beijing Office C405, Zoom

In a much-anticipated announcement, the National People's Congress released for public consultation on 3rd July the second draft amendments to the Patent Law. Significant changes include the introduction of a Patent Linkage system and a Supplemental Protection Period. These issues have long been discussed but there had been no further information released since the Supplemental Protection Period had been included in the previous draft on 4th January 2019.

The draft amendments to the Patent Law are open for public opinion until 16th August 2020. If you would like to send in comments through the chamber, please kindly submit your comments to sthe@europeanchamber.com.cn by 7th August.

The European Chamber is delighted to invite Ms Katherine Wang, Partner of Ropes & Gray life science group, to provide our members with a brief introduction on the second draft amendments of the Patent Law, with a focus on measures especially related to the pharmaceutical sectors.

• 2020-07-30 | 11:30 - 13:00
• Zoom online meeting

E-signature has become an important formality vehicle for entering into commercial contracts worldwide. What are e-signature’s implication and enforceability in Chinese commercial and judicial world? The European Chamber is delighted to invite you to our next working group meeting where Mr. HE Fang, partner of King & Wood Mallesons will present on the e-signature and Chinese e-signature law by sharing some real-life court cases.

• 2020-07-03 | 10:00 - 11:30
• Online (ZOOM) & Onsite(Beijing Chamber Office)

During the sharing session, Mr. Yun CHEN (Baker & McKenzie FenXun) and Ms. Elva Yao (Baker McKenzie) will conduct an interactive discussion focusing on the development of legal practice related to both trademark and patent infringement issues in Original Equipment Manufacturing (OEM).

• 2020-06-19 | 10:00 - 12:00
• Zoom meeting

The IP Tribunal of the Supreme People’s Court (SPC) recently issued a decision in Dunjun v. Tengda ((2019) SPC IP Civil No. 147), holding that the manufacturer’s making and selling of routers directly infringed a telecommunication method-of-use patent even though the manufacturer itself did not perform the patented method. This case is recognised the Chinese Akamai case.

The European Chamber is delighted to invite Mr. Steve SONG, Partner and Patent Attorney of Beijing DHH Law Firm, who represented the defendant in this landmark case to provide our members insights by studying the judgement of a few cases regarding multi-party patent infringement.

• 2020-05-29 | 14:30 - 16:20
• Zoom online meeting

A strong brand is instrumental in winning new customers when entering China’s market. As lot of time and money is spent on building brand reputation, it can be damaging to SMEs if someone else started to sell their products under the same brand name. Thus, brand protection is the key to success on China’s market. Successful protection, however, requires a comprehensive strategy, including registering IP such as trademarks, monitoring the market and taking action when spotting infringements.

• 2020-03-27 | 14:00 - 16:00
• ZOOM Online Meeting

We would like to invite you to attend the IPR Working Group election meeting on Patent Dispute on Novel Coronavirus Drug Remdeseviron 12th March, 14:00 – 16:00 via the digital platform Zoom (you will receive a link upon registration). This meeting will consist of three parts.

Firstly, this WG meeting will include the IPR Working Group 2020-2021 Chair elections. Only IPR WG members who had their registration confirmed for this meeting will have the right to vote online, with one vote per company. Online voting instructions will be sent via email to individual attendees prior to the meeting.

The second part of the WG meeting would be to discuss the Patent Issues with Novel Coronavirus Drug Remdesevir. At this meeting, Ms. Guo Songxi, Patent Counsel at Bayer China, will discuss the risks to IP Protection as it relates to the development of a drug to cure illness brought about by the novel coronavirus.

The third part of the Working Group meeting would be to brainstorm for the key recommendations for the 2020/2021 IPR position paper that will be drafted this coming half year (for the 2019/2020 IPR position paper click here).

• 2020-03-12 | 14:00 - 16:00
• ZOOM Online Meeting